Literature DB >> 1541052

Age-dependent responsiveness to interleukin-6 in B lymphocytes from a systemic lupus erythematosus-prone (NZB x NZW)F1 hybrid.

M E Alarcón-Riquelme1, G Möller, C Fernández.   

Abstract

The cellular mechanisms for the production of IgG anti-DNA antibodies were studied. Culture of T and B cells from old (NZB x NZW)F1 mice led to the production of IgG anti-DNA antibodies. We found that direct cell contact was partly necessary for the production of IgG anti-DNA antibodies. Fixation of the T cells showed that lymphokines were largely responsible for the antibody synthesis. Antibodies to mouse interleukin-6 (IL-6) inhibited the production of these antibodies in the T-B cell coculture. Human IL-6 could induce small "resting" B cells from the old (NZB x NZW)F1 mice to produce IgG anti-DNA antibodies in a dose-dependent fashion. The response was inhibited by an anti-human IL-6 monoclonal antibody. Large or small B cells from young (B/W)F1 mice or Balb/c mice were not induced by IL-6 to antibody production. Therefore, the capacity of the B/W mice to produce the IgG anti-DNA antibodies correlated with the ability of the B cells to respond to IL-6 and with the age at which the mice begin to have signs of the disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1541052     DOI: 10.1016/0090-1229(92)90101-s

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  13 in total

1.  Low-affinity, Smith antigen-specific B cells are tolerized by dendritic cells and macrophages.

Authors:  Michelle A Kilmon; Jennifer A Rutan; Stephen H Clarke; Barbara J Vilen
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

Review 2.  The role of cytokines in the immunopathogenesis of lupus.

Authors:  B S Handwerger; V Rus; L da Silva; C S Via
Journal:  Springer Semin Immunopathol       Date:  1994

3.  Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis.

Authors:  Susan Yung; Kwok Fan Cheung; Qing Zhang; Tak Mao Chan
Journal:  J Am Soc Nephrol       Date:  2010-09-16       Impact factor: 10.121

Review 4.  B-cell-targeted therapies in systemic lupus erythematosus.

Authors:  Vera Sau-Fong Chan; Helen Hoi-Lun Tsang; Rachel Chun-Yee Tam; Liwei Lu; Chak-Sing Lau
Journal:  Cell Mol Immunol       Date:  2013-01-28       Impact factor: 11.530

5.  Interleukin 6 promotes murine lupus in NZB/NZW F1 mice.

Authors:  B K Finck; B Chan; D Wofsy
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

Review 6.  Cytokines in systemic lupus erythematosus.

Authors:  Elaine V Lourenço; Antonio La Cava
Journal:  Curr Mol Med       Date:  2009-04       Impact factor: 2.222

Review 7.  Rationale for interleukin-6 blockade in systemic lupus erythematosus.

Authors:  E Tackey; P E Lipsky; G G Illei
Journal:  Lupus       Date:  2004       Impact factor: 2.911

8.  Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity?

Authors:  P E Spronk; E J ter Borg; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

9.  IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice.

Authors:  M Mihara; N Takagi; Y Takeda; Y Ohsugi
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

10.  Macrophage depletion decreases IgG anti-DNA in cultures from (NZB x NZW)F1 spleen cells by eliminating the main source of IL-6.

Authors:  M E Alarcón-Riquelme; G Möller; C Fernández
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.